Market Research Logo

Global Healthcare CMO Market (2017-2021 Edition)

Global Healthcare CMO Market (2017-2021 Edition)

Scope of the Report

This report named “Global Healthcare CMO Market (2017-2021 Edition)”, analysis the growth and sizing of global healthcare CMO market and its segments. This report provides the analysis of global healthcare CMO market by value and by segment.

The analysis of global medical device CMO market is done by value, by players and by cost structure and analysis of global pharmaceutical CMO is done by value and by segments. The global pharmaceutical CMO market by segments is analyzed in detail by providing analysis of each of its segment.

This report includes the analysis of global active pharmaceutical ingredient CMO market by value and analysis of finished dosage formulation CMO market by value, by revenue structure, by geographical approach and by dosage formulation.

This report also provides the analysis of global pharmaceutical CDMO market. This analysis includes the global pharmaceutical CDMO market by value, by players and by geography. The regional analysis of global pharmaceutical CDMO market is also done in this report. The regions included are United States of America, Europe, China and India.

This report also includes the growth drivers, market trends and challenges faced by global healthcare CMO market. Company profiling of major players of healthcare CMO industry is also done in this report. The companies included are Catalent Pharma Solution, Recipharm and Aurobindo Pharma Ltd. Business overview, financial overview and business strategies for each company is provided.

Country Coverage

The US
Europe
India
China

Company Coverage

Catalent Pharma Solutions Inc.
Recipharm
Aurobindo Pharma Limited

Executive Summary

Contract manufacturing is a type of outsourcing in which a firm contacts with a third party (contract manufacturing organization) for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm.

A big or a mid-sized firm opt for a CMO mainly for two reasons, either it wants to shift (or reduce) its cost and focus to its core activities, or the manufacturing of its products require special or expert handling.

From last few years, many pharmaceutical CMOs have included development part into their activities, apart from manufacturing of drugs and they are called contract development & manufacturing organizations (CDMOs). The market for pharmaceutical CMOs and CDMOs can neither be taken as same, nor be taken as completely distinct from each other. Also, these two markets cannot be combined together, as it will exaggerate the global pharmaceutical CMO market.

The global healthcare CMO market has recorded a continuous growth since last few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMO industry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceutical companies.


1. Executive Summary
2. Introduction
2.1 Contract Manufacturing: An Overview
2.1.1 Healthcare CMOs
2.1.2 Healthcare CMOs Market Segments
Table1: Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs
2.1.4 Medical CMOs
2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments
Table2: Pharmaceutical Outsourcing Market Segments
2.3 Pharmaceutical CMOs v/s CDMOs
Table3: Value Chain of a Drug
3. Global Market Analysis
3.1 Global Healthcare CMO Market: An Analysis
3.1.1 Global Healthcare CMO Market by Value
Table4: Global Healthcare CMO Market by Value; 2012-2016 (US$ Billion)
Table5: Global Healthcare CMO Market by Value; 2017-2021 (US$ Billion)
3.1.2 Global Healthcare CMO Market by Segments
Table6: Global Healthcare CMO Market by Segments; 2016
3.2 Global Medical Device CMO Market: An Analysis
3.2.1 Global Medical Device CMO Market by Value
Table7: Global Medical Device CMO Market by Value; 2012-2016 (US$ Billion)
Table8: Global Medical Device CMO Market by Value; 2017-2021 (US$ Billion)
3.3 Global Pharmaceutical CMO Market: An Analysis
3.3.1 Global Pharmaceutical CMO Market by Value
Table9: Global Pharmaceutical CMO Market by Value; 2012-2016 (US$ Billion)
Table10: Global Pharmaceutical CMO Market by Value; 2017-2021 (US$ Billion)
3.4 Global Pharmaceutical CMO Market: An Analysis
3.4.1 Global Pharmaceutical CMO Market by Segments
Table11: Global Pharmaceutical CMO Market by Segments; 2016
3.5 Global Pharmaceutical CMO Market: Segment Analysis
3.5.1 Global Active Pharmaceutical Ingredient CMO Market by Value
Table12: Global Active Pharmaceutical Ingredient CMO Market by Value; 2013-2016 (US$ Billion)
Table13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2017-2021 (US$ Billion)
3.5.2 Global Finished Dosage Formulation CMO Market by Value
Table14: Global Finished Dosage Formulation CMO Market by Value; 2013-2016 (US$ Billion)
Table15: Global Finished Dosage Formulation CMO Market by Value; 2017-2021 (US$ Billion)
3.6 Global Pharmaceutical CDMO Market: An Analysis
3.6.1 Global Pharmaceutical CDMO Market by Value
Table16: Global Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion)
Table17: Global Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion)
3.6.2 Global Pharmaceutical CDMO Market by Region
Table18: Global Pharmaceutical CDMO Market by Region; 2016
4. Regional Analysis
4.1 The US Pharmaceutical CDMO Market: An Analysis
4.1.1 The US Pharmaceutical CDMO Market by Value
Table19: The US Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion)
Table20: The US Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion)
4.2 Europe Pharmaceutical CDMO Market: An Analysis
4.2.1 Europe Pharmaceutical CDMO Market by Value
Table21: Europe Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion)
Table22: Europe Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion)
4.3 India Pharmaceutical CDMO Market: An Analysis
4.3.1 India Pharmaceutical CDMO Market by Value
Table23: India Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion)
Table24: India Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion)
4.4 China Pharmaceutical CDMO Market: An Analysis
4.4.1 China Pharmaceutical CDMO Market by Value
Table25: China Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion)
Table26: China Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion)
5. Competitive Landscape
5.1 Global Healthcare CMO Market Players Financial Comparison
Table 27: Global Healthcare CMO Market Players Financial Comparison; 2016
6. Company Profiling
6.1 Catalent Pharma Solutions Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
Table28: Catalent Revenue; 2012-2016 (US$ Billion)
Table29: Catalent Revenue by Segments; 2016
6.2 Recipharm
6.2.1 Business Overview
6.2.2 Financial Overview
Table30: Recipharm Net Sales; 2012-2016 (US$ Million)
Table31: Recipharm Net Sales by Segments; 2016
6.3 Aurobindo Pharma Limited
6.3.1 Business Overview
6.3.2 Financial Overview
Table32: Aurobindo Revenues; 2012-2016 (US$ Billion)
Table33: Aurobindo Revenues by Segments; 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report